Status:
COMPLETED
Feasibility of Immersive Virtual Reality Dietician Program in Metabolic-dysfunction Associated Steatotic Liver Disease
Lead Sponsor:
Milton S. Hershey Medical Center
Conditions:
Fatty Liver, Nonalcoholic
Weight Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Metabolic-dysfunction associated steatotic liver disease, often referred to as "fatty liver disease", is a leading cause of liver failure. Dietary weight loss is a cornerstone of treating fatty liver ...
Eligibility Criteria
Inclusion
- Adults age \>18 years
- MASLD identified on imaging
- Possession of a smartphone
Exclusion
- Inability to provide informed consent
- Institutionalized/prisoner
- Pregnant
- Other causes of hepatic steatosis or chronic liver disease
- Severe medical/psychiatric comorbidities at the study PI's discretion
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06215131
Start Date
July 1 2024
End Date
September 23 2025
Last Update
October 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State College of Medicine
Hershey, Pennsylvania, United States, 17033